EUROPEAN JOURNAL OF
PHARMACEUTICAL AND MEDICAL RESEARCH

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical, Medical & Biological Sciences

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

European Journal of Pharmaceutical and Medical Research (EJPMR) has indexed with various reputed international bodies like : Google Scholar , Indian Science Publications , InfoBase Index (In Process) , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , International Society for Research activity (ISRA) , Scientific Indexing Services (SIS) , Polish Scholarly Bibliography , Global Impact Factor (GIF) (Under Process) , Universal Impact Factor , International Scientific Indexing (ISI), UAE , Index Copernicus , CAS (A Division of American Chemical Society) USA (Under Process) , Directory of Open Access Journal (DOAJ, Sweden, in process) , UDLedge Science Citation Index , CiteFactor , Directory Of Research Journal Indexing (DRJI) , Indian citation Index (ICI) , Journal Index (JI, Under Process) , Directory of abstract indexing for Journals (DAIJ) , Open Access Journals (Under Process) , Impact Factor Services For International Journals (IFSIJ) , Cosmos Impact Factor , Jour Informatics (Under Process) , Eurasian Scientific Journal Index (ESJI) , International Innovative Journal Impact Factor (IIJIF) , Science Library Index, Dubai, United Arab Emirates , Pubmed Database [NLM ID: 101669306] (Under Process) , IP Indexing (IP Value 2.40) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Scope Database , Academia ,

ISSN 2394-3211

Impact Factor: 7.065

ICV - 79.57

Abstract

AN EVALUATION OF DYSLIPIDEMIA IN CHRONIC KIDNEY DISEASE AND ITS CORELATION TO STAGES OF CHRONIC KIDNEY DISEASE

*Dr. T. V. Sowmya M.D. and Dr. C. Arvind Kumar M.D.

ABSTRACT

In Osmania General Hospital, Lipid analysis is done in fasting state mainly for patients having risk of poor cardiovascular outcome. Experimental and clinical studies have suggested a correlation between the progression of renal disease and dyslipidemia. High Plasma cholesterol, LDL and Triglyceride level and low HDL level have been demonstrated to be independent risk factors for progression of renal disease from CKD stages 1-5 in humans. We conducted this study to evaluate the lipid abnormalities in various stages of chronic kidney disease on the background of these references. We used CKD -EPI formula to calculate the predicted creatinine clearance which is a rough estimation of G.F.R. in staging of Kidney disease.

Keywords: Chronic Kidney Disease, Low Density Lipoprotein, High Density Lipoprotein, Triglycerides, Diabetes Mellitus.

[Full Text Article] [Download Certificate]